RxDoctor Payments Data

Jonathan Garcia Julian, OD

Optometrist · Madison, WINPI 1326564436

Payments from drug & device makers

$1,968in general payments, 2019–2025

Across 49 payments — averaging $40.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$706
  • Alcon$491
  • Coopervision Inc.$289
  • Tarsus Pharmaceuticals, Inc.$244
  • Amgen$108
  • AbbVie$74
  • plus $56 from 2 others

What the payments were for

  • Consulting fees$201%
  • Food & beverage$1,94899%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bausch & Lomb Americas Inc.21$706
Alcon9$491
Coopervision Inc.13$289
Tarsus Pharmaceuticals, Inc.2$244
Amgen1$108
AbbVie1$74
The Cameron-ehlen Group, Inc.1$35
Oyster Point Pharma, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,968 in reported general payments places this provider in the 80th percentile of 867 optometrist providers in Wisconsin.

See all optometrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$15,895
Medicare patients
108
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost21$233

Paid to pharmacies, not to this prescriber.

Other optometrist in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →